Showing results (901-910 of 1,533) with videos related to
Sort By:
Pageof 154
Scientific Reports|May 25, 2016
An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitisMeng-Chen Lu, Jian-Ai Ji, Yong-Lin Jiang, et al.Organic Letters|April 3, 2020
Alternarin A, a Drimane Meroterpenoid, Suppresses Neuronal Excitability from the Coral-Associated Fungi <i>Alternaria</i> sp. ZH-15Hong-Liang Wang, Ran Li, Jiao Li, et al.Journal of Medicinal Chemistry|August 3, 2021
Discovery of 3,5-Dimethyl-4-Sulfonyl-1<i>H</i>-Pyrrole-Based Myeloid Cell Leukemia 1 Inhibitors with High Affinity, Selectivity, and Oral BioavailabilityPeng-Ju Zhu, Ze-Zhou Yu, Yi-Fei Lv, et al.Journal of Asian Natural Products Research|June 28, 2022
Two new iridoid glycosides from <i>Odontites vulgaris</i>Meng-Jie Wang, De Yang, Sheng-Bao Diao, et al.European Journal of Medicinal Chemistry|September 10, 2018
Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injuryLi-Li Xu, Yu-Feng Wu, Lei Wang, et al.Zhonghua Nan Ke Xue = National Journal of Andrology|February 26, 2011
[Nonsteroidal anti-inflammatory drug NS398 induces RECK expression in the animal model of prostate cancer]Zhen-Yu Xu, Jian-Ping Gao, Ying-Hao Sun, et al.Scientific Reports|July 21, 2017
Effect of septal flash on right ventricular systolic function in left bundle-branch block patients with preserved left ventricular ejection fractionGuang-Yuan Li, Yong-Huai Wang, Zheng-Yu Guan, et al.International Immunology|July 4, 2007
The effects of microenvironment and internal programming on plasma cell survivalHeather A Minges Wols, Jill A Ippolito, Zheng Yu, et al.Environmental Geochemistry and Health|June 6, 2009
Assessing heavy-metal contamination and sources by GIS-based approach and multivariate analysis of urban-rural topsoils in Wuhan, central ChinaMin Gong, Li Wu, Xiang-yang Bi, et al.Oncology Letters|September 10, 2014
A phase II trial of post-operative chemoradiotherapy for completely resected gastric cancer with D2 lymphadenectomyYu-Jie Zhai, Yi-Peng Su, Sheng-Jie Wang, et al.Pageof 154